Please sign in to follow a disease.
New pain block may reduce opioid use after gallbladder surgery
NCT ID NCT07164664
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two methods to control pain after laparoscopic gallbladder removal: a nerve block (external oblique intercostal block) and injecting pain medicine into the surgical cuts (port-site infiltration). Sixty adults were followed for 24 hours after surgery to see which method reduced pain and the need for strong painkillers (opioids). The goal is to find a better way to manage pain and limit opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Sep 2025
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18-75 undergoing elective Laparoscopic Cholecystectomy * American Society of Anesthesiologists (ASA)classification I-III patients. * Patients who can use PCA. * Patients who will sign the informed consent form. Exclusion Criteria: * They will refuse to participate. * They will have a body mass index (BMI) greater than 35 kg/m2. * They will have contraindications to peripheral nerve blocks (e.g., coagulopathy, abnormal INR, thrombocytopenia, local or systemic infection). * They will have clinically significant cardiovascular or cerebrovascular disease. * They will have severe hepatic, renal, or respiratory dysfunction. They will have known drug allergies. * They will have a history of substance abuse. * They will have chronic opioid use, defined as regular use of ≥15 mg oral morphine equivalent per day for at least 30 consecutive days within the past 3 months. * They will have chronic pain syndromes (e.g., fibromyalgia, diabetic neuropathy, or chronic low back pain). * They will have neuropsychiatric disorders or cognitive impairment that precludes effective communication with the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Opioid use are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ondokuz Mayis University
Samsun, 55139, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three ways to block hernia surgery pain go head to head
- Could a small electrical device cut painkiller use after hip surgery?
- Needle-Free pain relief: inhaled ketamine takes on fentanyl in the ER
- Can a blood pressure drug cut opioid needs during bowel surgery?
- Prisons as HIV prevention hubs: can opioid treatment reach more people behind bars?
- Two nerve blocks go head to head for breast surgery pain